Drug class

Gallstone Solubilizing Agents

Gallstone solubilizing agents, also known as cholelitholytic bile acid therapies, are a specialized therapeutic class of naturally occurring bile acids, primarily including ursodiol and chenodiol. Read more about Gallstone Solubilizing Agents

28 drugs in this class 27 manufacturers

Advertisement

Drugs in Gallstone Solubilizing Agents

Showing 19–27 of 28 drugs

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
STRIDES PHARMA

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
AUROBINDO PHARM

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
EYWA PHARMA INC

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
VGYAAN PHARMACE

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
FH2 PHARMA LLC

CTEXLI (chenodiol)

GALLSTONE SOLUBILIZING AGENTS · CEREBROTENDINOUS XANTHOMATOSIS
MIRUM PHARMACEU

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
PD-RX PHARM

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
AHP

URSODIOL

GALLSTONE SOLUBILIZING AGENTS · CHOLELITHIASIS PREVENTION ·+1
NORTHSTAR RX LL
Filter & compare in the drug finder → Opens the drug finder with Gallstone Solubilizing Agents preselected. Add indication or manufacturer filters there.

About Gallstone Solubilizing Agents.

Gallstone solubilizing agents, also known as cholelitholytic bile acid therapies, are a specialized therapeutic class of naturally occurring bile acids, primarily including ursodiol and chenodiol.

They function primarily by decreasing hepatic secretion and synthesis of cholesterol and reducing intestinal cholesterol absorption, which desaturates biliary cholesterol and facilitates the gradual dispersion and dissolution of cholesterol gallstones.

Clinically, these agents are utilized for the medical dissolution of small, radiolucent, non-calcified gallstones in patients who are non-surgical candidates, as well as for the prevention of gallstone formation during rapid weight loss.

Additionally, select agents within this class are indicated for chronic cholestatic hepatobiliary conditions, particularly primary biliary cholangitis.